American Journal of Physiology-Heart and Circulatory Physiology · 2000 · 30 citations · 35 references
MedicineCardiologyPharmacologyCardiovascular PharmacotherapyClinical CardiologyPharmacodynamicsCardiac PhysiologyCardiovascular MedicineCardiovascular PharmacodynamicsCardiovascular PharmacologyCardiovascular PhysiologyHemodynamic PharmacologyBaroreflex ControlBaroreflex PhysiologyBlood PressureBlood Pressure PharmacodynamicsCardiovascular Drug PharmacologyCardiovascular ReflexesHeart RatePharmacodynamics Of Cardiovascular Drugs
The effect of chronic activation or inhibition of central ANG II receptors on cardiac baroreflex function in conscious normotensive rabbits was examined. Animals received a fourth ventricular (4V) infusion of ANG II (30 and 100 ng/h), losartan (3 and 30 microg/h), or Ringer solution (2 microl/h) for 2 wk. After 1 and 2 wk, ANG II (100 ng/h) decreased cardiac baroreflex gain by 20 and 37%, respectively (P = 0.015), whereas losartan (30 microg/h) increased baroreflex gain by 24 and 58%, respectively (P = 0.02). Within 1 wk of the end of the infusions, cardiac baroreflex gain had returned to control. Ringer solution or the lower doses of ANG II or losartan did not modify the cardiac baroreflex function. Blood pressure and heart rate were not altered by any treatment, nor was their variability affected. These data demonstrate a novel long-term modulation of cardiac baroreflexes by endogenous ANG II that is independent of blood pressure level.
35
An Efficient Algorithm for Spectral Analysis of Heart Rate Variability
Ronald D. Berger, S. Akselrod, David Gordon et al. · IEEE Transactions on Biomedical Engineering · 1986 · 818 citations
Medicine, Cardiology, Physiology +16
Central Nervous System Control of Baroreceptor Reflexes in the Rabbit
Paul Körner, Jenny Shaw, MJ West et al. · Circulation Research · 1972 · 157 citations